After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

Add Yahoo as a preferred source to see more of our stories on Google. Neuromodulation systems are becoming increasingly popular for the treatment of UUI. Credit: designerNFMR / Shutterstock.com.

Please provide your email address to receive an email when new articles are posted on . The device significantly improved quality of life and symptoms among women with urgency urinary incontinence ...

UChicago Medicine has become the first medical center in Illinois to implant the Revi neuromodulation device, an exciting new treatment option that could offer relief for patients with urinary urgency ...

Recent study findings show postoperative location, urinary catheter insertion and use of an implantable device could be risk factors for surgical site infection among pediatric patients, according to ...

Amber Therapeutics Ltd. revealed positive data from the first-in-human investigation of its Amber-UI device, an implantable closed-loop bioelectrical therapy for urinary incontinence. Initial results ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

Study: Use of Implantable Device, Urinary Catheter Insertion Risk Factors for Pediatric Surgical Site Infections Study findings show postoperative setting, urinary catheter insertion and use of an ...